News Releases

News and information from The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society Statement on Proposed Cuts to NIH Budget

The Leukemia & Lymphoma Society (LLS) firmly opposes the Administration’s proposed budget, which reduces the funding for the National Institutes of Health (NIH) by $5.8 billion. These cuts risk derailing decades of advancement in the diagnosis, understanding and treatment of deadly blood cancers. LLS is calling upon members of Congress to reject these proposed cuts and increase funding for the NIH in future app...

Man & Woman of the Year is More than a Title, it’s all About Curing Cancer

Rye Brook, NY, March 17, 2017 – The adage says, “It’s not the titles that honor men, but the men who honor titles.” This could not be more accurate for the 900 men and women across the United States vying to win The Leukemia & Lymphoma Society’s (LLS) coveted title, Man & Woman of the Year (MWOY), conferred at the conclusion of this annual campaign. For 10 weeks, in 80 communities across the co...

LLS Appoints Dr. Gwen Nichols, Chief Medical Officer

  Rye Brook, N.Y. (March 16, 2017) – The Leukemia & Lymphoma Society (LLS), the world’s largest voluntary health agency dedicated to fighting blood cancer, announced it has appointed Gwen Nichols, M.D., chief medical officer (CMO). A physician and scientific researcher, Nichols has dedicated her career to advancing cures for cancers through a unique combination of clinical, academic and pharmaceut...

LLS AND BURLINGTON STORES HAVE RAISED MORE THAN $29 MILLION TO FIGHT CANCER

Rye Brook, NY (December 13, 2016) – Burlington Stores and The Leukemia & Lymphoma Society’s (LLS) Light The Night Walk® campaign collaborated for the 15th consecutive year to shine a light on the urgent need for funding to help support blood cancer research and advance new treatments and cures. From September 7 through November 30, all Burlington Stores nationwide encouraged customers to donate to the cause ...

New Research for the Holidays Shows It Is Better to Give Than Receive

View full multimedia release here Rye Brook, NY Nov. 30, 2016 – A new national survey by The Leukemia & Lymphoma Society (LLS), the world’s leading voluntary health non-profit dedicated to fighting blood cancers, finds that an overwhelming majority of Americans (90%) say they believe the true meaning of the holidays is to help others and 87% say they wish they could do more to help others in need. Eight in...

LLS Receives Prestigious Innovation Impact Award to “Reach the Unreached”

Rye Brook, NY – November 30, 2016 – The Leukemia & Lymphoma Society (LLS) was awarded the 2016 Celgene Innovation Impact award for an initiative that will allow the organization to “Reach the Unreached” with education and support for blacks, who are at twice the risk for multiple myeloma as whites. LLS’s initiative, “Taking it to Church: Enhancing Myeloma Knowledge and Access to Latest Treatments i...

LLS Invests $40.3 Million in New Research to Find Cures

View full multimedia release here   Rye Brook, NY – November 16, 2016 – The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cance...

MD Anderson Starts LLS-Funded Clinical Trial for Acute Myeloid Leukemia

Houston, TX- October 26, 2016 -- The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) has initiated the first clinical study of a novel drug designed to starve cancer cells, IACS-10759. The study will enroll patients with acute myeloid leukemia (AML) and is supported by a $3.5 million investment from The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Progr...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: